Research and analysis

SPI-B: Antibody tests: realise benefits and minimize harms - note, 1 April 2020

Paper prepared by Scientific Pandemic Influenza Group on Behaviours (SPI-B) for the Scientific Advisory Group for Emergencies (SAGE).

• From: Scientific Advisory Group for Emergencies
• Published: 29 May 2020

Documents

Antibody tests: Notes on misclassification, misunderstanding, misuse and mitigation to realise benefits and minimize harms - note from SPI-B - 1 April 2020

PDF, 198 KB, 3 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Paper prepared by SPI-B on on the misclassification, misunderstanding, misuse and mitigation associated with antibody tests and immunity. It was discussed at SAGE 22 on 22 April 2020.

It should be viewed in context: the paper was the best assessment of the evidence at the time of writing. The picture is developing rapidly and, as new evidence or data emerges, SAGE updates its advice accordingly.

Therefore, some of the information in this paper may have been superseded and the author’s opinion or conclusion may since have developed.

These documents are released as pre-print publications that have provided the government with rapid evidence during an emergency. These documents have not been peer-reviewed and there is no restriction on authors submitting and publishing this evidence in peer-reviewed journals.

Published 29 May 2020